Status:
COMPLETED
Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions
Lead Sponsor:
Alvogen Korea
Conditions:
Healthy
Eligibility:
MALE
20-55 years
Phase:
PHASE1
Brief Summary
A randomized, open-label, single-dose, crossover clinical trial to evaluate the food effect on the pharmacokinetics of DP-R202 tablet after oral administration in healthy male volunteers.
Detailed Description
The number of patient is twenty-four.Patients were randomly assigned either DP-R202(Sarpogrelate HCL 300mg, qd) under fasting condition or DP-R202(Sarpogrelate HCL 300mg, qd) after eating foods.
Eligibility Criteria
Inclusion
- 20 to 55 years of healthy volunteers
Exclusion
- Hypersensitivity Reaction about Sarpogrelate HCL or other antiplatelets
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01421576
Start Date
July 1 2011
End Date
July 1 2011
Last Update
August 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Gangnam, South Korea, 135-710